Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage

被引:117
作者
Du, H
Duanmu, M
Witte, D
Grabowski, GA
机构
[1] Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH 45229 USA
[2] Childrens Hosp Res Fdn, Div Pathol, Cincinnati, OH 45229 USA
关键词
D O I
10.1093/hmg/7.9.1347
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lysosomal acid lipase (LAL) is essential for the hydrolysis of the triglycerides and cholesteryl esters in lysosomes, Its deficiency produces two phenotypes, a severe infantile-onset variant, Wolman disease (WD), and a later onset variant, cholesteryl ester storage disease (CESD), A mouse model with a LAL null mutation was produced by targeting disruption of the mouse gene. Homozygote knockout mice (lal(-)/lal(-)) produce no LAL mRNA, protein or enzyme activity, The lal(-)/lal(-) mice are born in Mendelian ratios, are normal appearing at birth, and follow normal development into adulthood. However, massive accumulation of triglycerides and cholesteryl esters occurs in several organs, By 21 days, the liver develops a yellow-orange color and is similar to 1.5-2.0x larger than normal, The accumulated cholesteryl esters and triglycerides are similar to 30-fold greater than normal. The lal(+)/lal(-) mice have similar to 50% of normal LAL activity and do not show lipid accumulation. Male and female lal(-)/lal(-) mice are fertile and can be bred to produce progeny, This mouse model is a phenotypic model of human CESD, and a biochemical and histopathologic mimic of human WD, The lal(-)/lal(-) mice provide a model to determine the role of LAL in lipid metabolism and the pathogenesis of its deficiency states.
引用
收藏
页码:1347 / 1354
页数:8
相关论文
共 42 条
[1]   PURIFICATION, CHARACTERIZATION AND MOLECULAR-CLONING OF HUMAN HEPATIC LYSOSOMAL ACID LIPASE [J].
AMEIS, D ;
MERKEL, M ;
ECKERSKORN, C ;
GRETEN, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 219 (03) :905-914
[2]  
AMEIS D, 1995, J LIPID RES, V36, P241
[3]  
ANDERSON RA, 1991, J BIOL CHEM, V266, P22479
[4]   INSITU LOCALIZATION OF THE GENETIC-LOCUS ENCODING THE LYSOSOMAL ACID LIPASE CHOLESTERYL ESTERASE (LIPA) DEFICIENT IN WOLMAN-DISEASE TO CHROMOSOME-10Q23.2-Q23.3 [J].
ANDERSON, RA ;
RAO, N ;
BYRUM, RS ;
ROTHSCHILD, CB ;
BOWDEN, DW ;
HAYWORTH, R ;
PETTENATI, M .
GENOMICS, 1993, 15 (01) :245-247
[5]   MUTATIONS AT THE LYSOSOMAL ACID CHOLESTERYL ESTER HYDROLASE GENE LOCUS IN WOLMAN-DISEASE [J].
ANDERSON, RA ;
BYRUM, RS ;
COATES, PM ;
SANDO, GN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2718-2722
[6]   GENOMIC ORGANIZATION OF THE HUMAN LYSOSOMAL ACID LIPASE GENE (LIPA) [J].
ASLANIDIS, C ;
KLIMA, H ;
LACKNER, KJ ;
SCHMITZ, G .
GENOMICS, 1994, 20 (02) :329-331
[7]   Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity [J].
Aslanidis, C ;
Ries, S ;
Fehringer, P ;
Buchler, C ;
Klima, H ;
Schmitz, G .
GENOMICS, 1996, 33 (01) :85-93
[8]  
Assmann G, 1995, METABOLIC MOL BASES, P2563
[9]  
BROWN MS, 1980, J LIPID RES, V21, P505
[10]   LYSOSOMAL ACID LIPASE IN CULTIVATED FIBROBLASTS - CHARACTERIZATION OF ENZYME-ACTIVITY IN NORMAL AND ENZYMATICALLY DEFICIENT CELL-LINES [J].
BURTON, BK ;
EMERY, D ;
MUELLER, HW .
CLINICA CHIMICA ACTA, 1980, 101 (01) :25-32